Clinical Trial Update: A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating quetiapine fumarate sustained release for major depressive disorder with comorbid fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia
• Major Depressive Disorder

Drugs mentioned

• Quetiapine Fumarate Sustained Release (quetiapine fumarate)

Snippet

Sponsor: Dr Alexander McIntyre Inc. | Conditions: Major Depression | Phase 4 | Status: COMPLETED